Caplin Point Laboratories Ltd's sterile product manufacturing subsidiary Caplin Steriles Ltd has received approval from the US Food and Drug Administration to market Thiamine Hydrochloride injection USP, the company said via an exchange filing.
The injection is a generic of Thiamine Hydrochloride injection of Fresenius Kabi USA LLC.
Thiamine Hydrochloride injection is used in the treatment of Thiamine, or Vitamin B1, deficiency and beriberi, a serious condition caused by a prolonged lack of Vitamin B1 in the body.
The Thiamine Hydrochloride injection had sales of $38 mln for the year ending September in the US, according to data by IQVIA.
SSC JE 2025: Registration Window For 1,340 Vacancies Closes Tomorrow; Check Exam Pattern Here
Gaurav Gogoi Flags 3 Key Issues For PM Modi Ahead Of Parliament Monsoon Session (VIDEO)
AAP Chief Arvind Kejriwal, Sanjay Singh Meet Vice President Jagdeep Dhankhar Ahead Of Monsoon Session
Congress To Raise Full Statehood Demand For Jammu And Kashmir During Monsoon Parliament Session
Shares of Caplin Point Laboratories traded 0.8% higher at ₹671.15 on NSE, at 11:15 IST.
